WILLINGNESS OF WOMEN WITH ENDOMETRIOSIS PLANNING TO UNDERGO IVF TO PARTICIPATE IN A RANDOMIZED CLINICAL TRIAL AND THE EFFECTS OF THE COVID-19 PANDEMIC ON POTENTIAL PARTICIPATION.
A brief survey was sent to women who were diagnosed with endometriosis, undergoing fertility treatment, and were within the University of Colorado healthcare system: the survey gathered information on whether these women would consider being apart of a clinical trial and whether their experiences with delays in IVF treatments due to COVID-19 would influence their consideration of a 8-week treatment prior to their IVF cycle. This survey was distributed to gather information about women who may quality for the PREGnant study for women diagnosed with endometriosis who may be randomized to an experimental group that undergoes a 60-day treatment with an GnRH antagonist prior to IVF start. Results from the survey suggest that the COVID-19 pandemic would influence the decisions of some women to delay IVF treatment to participate in a trial.